Which breathing aid wins for COVID-19? HVNI vs CPAP showdown
NCT ID NCT07213518
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 108 adults with COVID-19 pneumonia who had low oxygen levels (type 1 respiratory failure). Researchers compared two breathing support methods: High-Velocity Nasal Insufflation (HVNI) and Continuous Positive Airway Pressure (CPAP). The goal was to see which one corrects low oxygen better. The study is now complete.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mohamed AbdElmoniem
Al Mansurah, 35516, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple inhaled combo keep pneumonia patients off ventilators?
- Simple breathing and walking exercises may speed lung recovery after COVID-19 pneumonia
- Can a smartphone app heal the hidden wounds of the ICU?
- Ultrasound peek at lungs after COVID: small study, big questions
- Could stem cells help COVID-19 patients breathe easier?
- Vaccinated still got COVID: new study counts breakthrough cases